Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03268590 · ClinicalTrials.gov registry record · Phase 4
Neuroimaging During Pure Oxygen Breathing
A Phase 4 study, sponsored by Case Western Reserve University.
- Completed
- Registry status
- Phase 4
- Development phase
- 33
- Enrollment target
NCT03268590 is a Phase 4 study that has completed, run by Case Western Reserve University. The registered enrollment target is 33 participants.
The verdict
NCT03268590, a Phase 4 study, has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 33 participants
- Enrollment target
Study Summary
The investigators will conduct a non-randomized clinical trial to examine the effect of pure oxygen breathing on the brain. The study will compare cerebral blood flow, cortical electrical activity, and cognitive performance in 32 persons during room air (21% oxygen) breathing and pure oxygen (100% oxygen) breathing. Subjects will be used as their own controls. The investigators aim to: 1. Determine whether breathing 100% oxygen changes blood flow through the brain. The investigators will learn whether brain blood flow is increased, decreased or stays the same. 2. Determine if changes that might occur in brain blood flow are also accompanied by changes in the brain's electrical activity (EEG). 3. Learn whether changes in the speed at which the brain processes information (cognitive function) accompany changes in brain blood flow and electrical activity that may be seen.
Interventions
- DRUG Oxygen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2017-10-02 |
| Est. Completion | 2018-05-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03268590
The ClinicalTrials.gov registry entry for NCT03268590 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oxygen is the first listed.
NCT03268590 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03268590 about?
NCT03268590 is a clinical study titled "Neuroimaging During Pure Oxygen Breathing". The investigators will conduct a non-randomized clinical trial to examine the effect of pure oxygen breathing on the brain. The study will compare cerebral blood flow, cortical electrical activity, and cognitive performance in 32 persons during room air (21% oxygen) breathing and pure oxygen (100% o...
What is the current status of trial NCT03268590?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 33 participants. The study started on 2017-10-02. Estimated completion is 2018-05-09.
What interventions are being tested in trial NCT03268590?
The interventions under investigation include: Oxygen (DRUG).
Who is sponsoring clinical trial NCT03268590?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.